DrugPatentWatch Database Preview
Exela Pharma Scs Llc Company Profile
What is the competitive landscape for EXELA PHARMA SCS LLC, and when can generic versions of EXELA PHARMA SCS LLC drugs launch?
EXELA PHARMA SCS LLC has eight approved drugs.
There is one US patent protecting EXELA PHARMA SCS LLC drugs.
Summary for Exela Pharma Scs Llc
| US Patents: | 1 |
| Tradenames: | 8 |
| Ingredients: | 8 |
| NDAs: | 8 |
Drugs and US Patents for Exela Pharma Scs Llc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exela Pharma Scs Llc | MAGNESIUM SULFATE | magnesium sulfate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 206039-001 | Dec 18, 2014 | AP | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Exela Pharma Scs Llc | NIPRIDE RTU IN SODIUM CHLORIDE 0.9% | sodium nitroprusside | SOLUTION;INTRAVENOUS | 209387-001 | Mar 8, 2017 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Exela Pharma Scs Llc | GLYRX-PF | glycopyrrolate | SOLUTION;INTRAMUSCULAR, INTRAVENOUS | 210997-002 | Jul 11, 2018 | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
